Mobile device for disease diagnosis and data tracking in resource-limited settings

Clinical Chemistry

Volumn 59, Issue 4, 2013, Pages 629-640

  Chin, Curtis D ^a   Cheung, Yuk Kee ^a   Laksanasopin, Tassaneewan ^a   Modena, Mario M ^a   Chin, Sau Yin ^a   Sridhara, Archana A ^a   Steinmiller, David ^b   Linder, Vincent ^b   Mushingantahe, Jules ^c   Umviligihozo, Gisele ^d   Karita, Etienne ^d   Mwambarangwe, Lambert ^e   Braunstein, Sarah L ^e,f   De Wijgert, Janneke Van ^e,g   Sahabo, Ruben ^h   Justman, Jessica E ^f,h   El Sadr, Wafaa ^f,h   Sia, Samuel K ^a  

^a Columbia University ^*  (United States)

^b OPKO Health Inc   (United States)

^c Department of Obstetrics and Gynecology Muhima Hospital   (Rwanda)

^d Project San Francisco   (Rwanda)

^e Projet Ubuzima   (Rwanda)

^f Och Spine at New York Presbyterian Hospitals   (United States)

^g UNIVERSITY OF AMSTERDAM   (Netherlands)

^h NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY TITER; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; DIAGNOSTIC ACCURACY; DIAGNOSTIC EQUIPMENT; DIAGNOSTIC TEST ACCURACY STUDY; ELECTRONIC MEDICAL RECORD; ELECTRONICS; ENZYME LINKED IMMUNOSORBENT ASSAY; HIV RAPID TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; MAJOR CLINICAL STUDY; MOBILE MICROFLUIDIC CHIP FOR IMMUNOASSAY ON PROTEIN MARKERS DEVICE; MOBILE PHONE; NONHUMAN; RWANDA; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SEXUALLY TRANSMITTED DISEASE; TELECOMMUNICATION; VIRUS HEPATITIS;

AIDS SERODIAGNOSIS; CELLULAR PHONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MEDICALLY UNDERSERVED AREA; MINIATURIZATION; RWANDA;

EID: 84875860066     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2012.199596     Document Type: Article

References (46)

1. Morris K. Mobile phones connecting efforts to tackle infectious disease. Lancet Infect Dis 2009; 9:274.
2. Lester R, Karanja S. Mobile phones: exceptional tools for HIV/AIDS, health, and crisis management. Lancet Infect Dis 2008;8:738 -9.
3. Zurovac D, Sudoi RK, Akhwale WS, Ndiritu M, Hamer DH, Rowe AK, Snow RW. The effect of mobile phone text-message reminders on Kenyan health workers' adherence to malaria treatment guidelines: a cluster randomised trial. Lancet 2011;378:795-803.
4. Pop-Eleches C, Thirumurthy H, Habyarimana JP, Zivin JG, Goldstein MP, de Walque D, et al. Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS 2011;25:825-34.
5. Lester RT, Ritvo P, Mills EJ, Kariri A, Karanja S, Chung MH, et al. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet 2010;376:1838-45.
6. Bellina L, Missoni E. Mobile cell-phones (Mphones) in telemicroscopy: increasing connectivity of isolated laboratories. Diagn Pathol 2009;4: 19.
7. Blaya JA, Cohen T, Rodriguez P, Kim J, Fraser HS. Personal digital assistants to collect tuberculosis bacteriology data in Peru reduce delays, errors, and workload, and are acceptable to users: cluster randomized controlled trial. Int J Infect Dis 2009;13:410-8.
8. Willyard C. Focus on electronic health records. Electronic records pose dilemma in developing countries. Nat Med 2010;16:249.
9. Fraser HS, Biondich P, Moodley D, Choi S, Mamlin BW, Szolovits P. Implementing electronic medical record systems in developing countries. Inform Prim Care 2005;13:83-95.
10. Nsanzimana S, Ruton H, Lowrance DW, Cishahayo S, Nyemazi JP, Muhayimpundu R, et al. Cell phone-based and internet-based monitoring and evaluation of the national antiretroviral treatment program during rapid scale-up in Rwanda: Tracnet, 2004-2010. J Acquir Immune Defic Syndr 2012;59:e17-23.
11. NIH. A summit on mobile technologies as a platform for health research and healthcare delivery. http://www.fic.nih.gov/news/events/mhealth summit.htm (Accessed November 2012).
12. Schreiner S. Inaugural mHealth summit successfully brings together health, technology and policy communities to advance technological innovation in global healthcare. Business Wire October 2009. http://www.reuters.com/article/ 2009/10/30/idUS194707-30-Oct-2009-BW20091030 (Accessed December 2012).
13. Kost GJ. Part III: point-of-care testing in health system, community and field. In: Principles & practice of point-of-care testing. Baltimore: Lippincott Williams & Wilkins; 2002. p 386.
14. Centers for Disease Control. Flu activity & surveillance. http://www.cdc.gov/flu/weekly/fluactivitysurv. htm (Accessed November 2012).
15. Dzenowagis J. Connecting for health : global vision, local insight. Report for the World Summit on the Information Society. Geneva: WHO; 2005. http://apps.who.int/iris/bitstream/10665/43385/1/9241593903-eng.pdf (Accessed December 2012).
16. Chin CD, Laksanasopin T, Cheung YK, Steinmiller D, Linder V, Parsa H, et al. Microfluidics-based diagnostics of infectious diseases in the developing world. Nat Med 2011;17:1015-9.
17. Donovan BJ, Rublein JC, Leone PA, Pilcher CD. HIV infection: point-of-care testing. Ann Pharmacother 2004;38:670-6.
18. WHO. HIV assays: operational characteristics: report 14 simple/rapid tests. Geneva: WHO; 2004.
19. Gray RH, Makumbi F, Serwadda D, Lutalo T, Nalugoda F, Opendi P, et al. Limitations of rapid HIV-1 tests during screening for trials in Uganda: diagnostic test accuracy study. BMJ 2007;335: 188-90.
20. Pavie J, Rachline A, Loze B, Niedbalski L, Delaugerre C, Laforgerie E, et al. Sensitivity of five rapid HIV tests on oral fluid or finger-stick whole blood: a real-time comparison in a healthcare setting. PLoS One 2010;5:e11581.
21. Plate DK, Wiktor S, Demby A, Crippen P, Diaz T, Plate D, et al. Evaluation and implementation of rapid HIV tests: the experience in 11 African countries. AIDS Res. Hum Retroviruses 2007;23: 1491-8.
22. Mulhern J III. Approximate desktop, notebook, & netbook power usage. http://www.upenn.edu/computing/provider/docs/hardware/powerusage.html (Accessed November 2012).
23. Parsa H, Chin CD, Mongkolwisetwara P, Lee BW, Wang JJ, Sia SK. Effect of volume- and timebased constraints on capture of analytes in microfluidic heterogeneous immunoassays. Lab Chip 2008;8:2062-70.
24. Deep UD, Petersen BR, Meng J. A smart microcontroller-based iridium satellite-communication architecture for a remote renewable energy source. Power Delivery, IEEE Transactions 2009;24:1869 -75.
25. Braunstein SL, Ingabire CM, Kestelyn E, Uwizera AU, Mwamarangwe L, Ntirushwa J, et al. High human immunodeficiency virus incidence in a cohort of Rwandan female sex workers. Sex Transm Dis 2011;38:385-94.
26. US Food and Drug Administration. July 22, 2004 Approval letter-abbott HIVAB HIV-1/HIV-2 (rDNA) EIA. http://www.fda.gov/BiologicsBlood Vaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/ BloodDonorScreening/InfectiousDisease/ucm091149.htm (Accessed November 2012).
27. Mendenhall CL, Roselle GA, Grossman CJ, Rouster SD, Weesner RE. False positive tests for HTLV-III antibodies in alcoholic patients with hepatitis. N Engl J Med 1986;314:921-2.
28. Nuwayhid NF. Laboratory tests for detection of human immunodeficiency virus type 1 infection. Clin Diagn Lab Immunol 1995;2:637-45.
29. Fleming DW, Cochi SL, Steece RS, Hull HF. Acquired immunodeficiency syndrome in lowincidence areas. How safe is unsafe sex? JAMA 1987;258:785-7.
30. Steece R, Fleming DW. False-positive HIV antibody tests in RPR-reactive patients: reply. JAMA 1988;260:923-4.
31. Challakere K, Rapaport MH. False-positive human immunodeficiency virus type I ELISA results in low-risk subjects. West J Med 1993;159:214 -5.
32. Banoo S, Bell D, Bossuyt P, Herring A, Mabey D, Poole F, et al. Evaluation of diagnostic tests for infectious diseases: general principles. Nat Rev Microbiol 2006;4:S20 -32.
33. WHO. Operational characterisitics of commercially available assays to determine antibodies to HIV-1 and/or HIV-2 in human sera: report 11. Geneva: WHO; 1999. http://hinfo.humaninfo.ro/gsdl/healthtechdocs/en/m/abstract/Js15204e/ (Accessed January 2013).
34. WHO. HIV assays: Operational characteristics: report 15 antigen/antibody ELISAs. Geneva: WHO; 2004. http://www.who.int/diagnostics-laboratory/ publications/en/HIV-Report15.pdf (Accessed December 2012).
35. Patel P, Klausner JD, Bacon OM, Liska S, Taylor M, Gonzalez A, et al. Detection of acute HIV infections in high-risk patients in California. J Acquir Immune Defic Syndr 2006;42:75-9.
36. Serna-Bolea C, Munoz J, Almeida JM, Nhacolo A, Letang E, Nhampossa T, et al. High prevalence of symptomatic acute HIV infection in an outpatient ward in southern Mozambique: identification and follow-up. AIDS 2010;24:603-8.
37. Nieuwenhuis J, van Kasteel M. The role of consumer electronics in point-of-care testing. In: Price P, St John A, Kricka LJ, eds. Point-of-care testing. 3rd ed. Washington (DC): AACC Press; 2010. p 97-106.
38. Plebani M. Does POCT reduce the risk of error in laboratory testing? Clin Chim Acta 2009;404:59-64.
39. Whitesides GM. The origins and the future of microfluidics. Nature 2006;442:368 -73.
40. Yager P, Edwards T, Fu E, Helton K, Nelson K, Tam MR, Weigl BH. Microfluidic diagnostic technologies for global public health. Nature 2006; 442:412-8.
41. Malkin RA. Design of health care technologies for the developing world. Annu Rev Biomed Eng 2007;9:567-87.
42. Braun RP, Vecchietti JL, Thomas L, Prins C, French LE, Gewirtzman AJ, et al. Telemedical wound care using a new generation of mobile telephones: a feasibility study. Arch Dermatol 2005;141:254-8.
43. Dziadzio M, Hamdulay S, Reddy V, Boyce S, Keat A, Andrews J. A still image of a transient rash captured by a mobile phone. Clin Rheumatol 2007;26:979-80.
44. Martinez AW, Phillips ST, Carrilho E, Thomas SW III, Sindi H, Whitesides GM. Simple telemedicine for developing regions: camera phones and paper-based microfluidic devices for real-time, off-site diagnosis. Anal Chem 2008;80:3699-707.
45. Smith ZJ, Chu K, Espenson AR, Rahimzadeh M, Gryshuk A, Molinaro M, et al. Cell-phone-based platform for biomedical device development and education applications. PLoS One 2011;6:e17150.
46. Kaplan WA. Can the ubiquitous power of mobile phones be used to improve health outcomes in developing countries? Global Health 2006;2:9.